Molina Healthcare (NYSE:MOH) Issues FY 2026 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 5.000- for the period, compared to the consensus estimate of 12.950. The company issued revenue guidance of -, compared to the consensus revenue estimate of $46.9 billion.

Molina Healthcare Trading Down 25.5%

NYSE MOH opened at $131.78 on Friday. Molina Healthcare has a 52 week low of $125.00 and a 52 week high of $359.97. The company has a 50 day moving average price of $173.19 and a 200 day moving average price of $170.90. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. The firm has a market cap of $7.14 billion, a PE ratio of 15.39 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($3.18). The firm had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a return on equity of 13.37% and a net margin of 1.04%.Molina Healthcare’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.05 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts forecast that Molina Healthcare will post 24.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. TD Cowen cut shares of Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price objective on the stock. in a research note on Thursday, October 16th. Cantor Fitzgerald dropped their target price on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $224.00 price objective on shares of Molina Healthcare in a research note on Tuesday, January 6th. The Goldman Sachs Group cut their price target on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a research note on Friday, October 24th. Finally, UBS Group dropped their price objective on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $182.64.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the transaction, the director directly owned 11,352 shares in the company, valued at $1,623,563.04. This trade represents a 3.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare News Summary

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Q4 revenue beat — Molina reported $11.38B in Q4 sales, up ~8% year-over-year and above consensus, showing top-line growth despite cost pressures. Molina Healthcare Reports Fourth Quarter and Year-End 2025 Financial Results
• Positive Sentiment: High-profile investor support — Michael Burry has reportedly remained positive on MOH, which could attract contrarian interest and buying at lower levels. Should You Buy the Dip in This Oversold Michael Burry Stock?
• Neutral Sentiment: Earnings call transcript available — Management discussed drivers of the quarter and outlook on the Q4 earnings call; review for details on cost trends and segment performance. Molina Healthcare, Inc. Q4 2025 Earnings Call Transcript
• Negative Sentiment: Massive EPS miss — Molina reported a surprise Q4 loss of ($2.75) per share vs. an expected ~$0.43, a swing that shocked investors and eroded confidence in near-term profitability. Molina (MOH) Reports Q4 Loss, Tops Revenue Estimates
• Negative Sentiment: Severe guidance cut — Management set FY2026 EPS guidance around $5.00 vs. analyst consensus near $12.95, signaling continued margin pressure (driving much of today’s selloff). Molina Healthcare forecasts 2026 profit below estimates
• Negative Sentiment: Rising medical costs & exchange headwinds — Management cited surging medical costs in its ACA/exchange business and policy uncertainty as key drags on profit recovery. Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge
• Negative Sentiment: Analyst reaction and downgrades — Street reaction includes cuts and a reiterated sell/underperform with lower price targets, increasing downside risk near term. Molina Healthcare: Slashed Earnings Outlook, Exchange Contraction, and Policy Uncertainty Drive Underperform (Sell) Rating
• Negative Sentiment: Market reaction — Major outlets report the stock plunged on the surprise loss and weak outlook, with heavy trading volume as investors reprice risk. Molina plunges after issuing 2026 profit forecast much below expectations

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in MOH. AQR Capital Management LLC lifted its position in shares of Molina Healthcare by 217.0% during the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the period. UBS Group AG grew its holdings in shares of Molina Healthcare by 320.7% in the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after acquiring an additional 460,372 shares during the period. Viking Global Investors LP purchased a new position in Molina Healthcare in the 2nd quarter valued at approximately $79,665,000. BNP Paribas Financial Markets raised its holdings in Molina Healthcare by 130.8% during the third quarter. BNP Paribas Financial Markets now owns 269,632 shares of the company’s stock worth $51,597,000 after purchasing an additional 152,783 shares during the last quarter. Finally, Man Group plc boosted its position in Molina Healthcare by 1,551.9% during the second quarter. Man Group plc now owns 127,132 shares of the company’s stock worth $37,873,000 after purchasing an additional 119,436 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.